nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anaphylaxis to Leuprolide Acetate Depot Injection During Treatment for Prostate Cancer
|
Grant Jr, John P. |
|
2007 |
5 |
4 |
p. 284-286 3 p. |
artikel |
2 |
Highlights from: The 2007 Prostate Cancer Symposium, February 22–24, 2007; Orlando, FL
|
Gupta, Manisha |
|
2007 |
5 |
4 |
p. 249-255 7 p. |
artikel |
3 |
Radiation Therapy and Sorafenib: Clinical Data and Rationale for the Combination in Metastatic Renal Cell Carcinoma
|
Kasibhatla, Mohit |
|
2007 |
5 |
4 |
p. 291-294 4 p. |
artikel |
4 |
Selected Clinical Trials in Prostate and Bladder Cancer
|
|
|
2007 |
5 |
4 |
p. 295- 1 p. |
artikel |
5 |
Spontaneous Intraperitoneal Perforation of the Bladder: A Late Complication of Radiation Therapy for Prostate Cancer
|
Ketata, Sabeur |
|
2007 |
5 |
4 |
p. 287-290 4 p. |
artikel |
6 |
The Effect of Zoledronic Acid on Bone Mineral Density in Patients Undergoing Androgen Deprivation Therapy
|
Israeli, Ron S. |
|
2007 |
5 |
4 |
p. 271-277 7 p. |
artikel |
7 |
The Prognostic Significance of Epidermal Growth Factor Receptor Expressionin Clear-Cell Renal Cell Carcinoma: A Call for Standardized Methods for Immunohistochemical Evaluation
|
Cohen, David |
|
2007 |
5 |
4 |
p. 264-270 7 p. |
artikel |
8 |
Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial
|
Hainsworth, John D. |
|
2007 |
5 |
4 |
p. 278-283 6 p. |
artikel |
9 |
What Is Standard Initials Systemic Therapy in Metastatic Renal Cell Carcinoma?
|
Rini, Brian I. |
|
2007 |
5 |
4 |
p. 256-263 8 p. |
artikel |